1. Home
  2. MVBF vs HUMAW Comparison

MVBF vs HUMAW Comparison

Compare MVBF & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MVB Financial Corp.

MVBF

MVB Financial Corp.

HOLD

Current Price

$27.79

Market Cap

333.7M

Sector

Finance

ML Signal

HOLD

Logo Humacyte Inc. Warrant

HUMAW

Humacyte Inc. Warrant

N/A

Current Price

$0.15

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MVBF
HUMAW
Founded
1997
2004
Country
United States
United States
Employees
N/A
220
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
333.7M
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MVBF
HUMAW
Price
$27.79
$0.15
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$27.60
N/A
AVG Volume (30 Days)
74.4K
14.2K
Earning Date
10-29-2025
03-21-2025
Dividend Yield
2.44%
N/A
EPS Growth
73.99
N/A
EPS
2.45
N/A
Revenue
$167,853,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$14.06
N/A
P/E Ratio
$11.37
N/A
Revenue Growth
18.75
N/A
52 Week Low
$15.59
$1.18
52 Week High
$28.72
$1.34

Technical Indicators

Market Signals
Indicator
MVBF
HUMAW
Relative Strength Index (RSI) 62.40 44.95
Support Level $26.52 $0.11
Resistance Level $28.72 $0.15
Average True Range (ATR) 0.69 0.03
MACD 0.12 0.00
Stochastic Oscillator 72.70 91.78

Price Performance

Historical Comparison
MVBF
HUMAW

About MVBF MVB Financial Corp.

MVB Financial Corp is a bank holding company. The company provides Personal banking, Business banking, and Fintech solutions. The group has identified three reportable segments: CoRe Banking, Mortgage Banking, and Financial Holding Company. The majority of ts revenue generated from the CoRe Banking segment, which includes the Fintech division, represents banking products and services offered to customers by the Bank, loans, and deposit accounts. Revenue from banking activities consists of interest earned on loans and investment securities and service charges on deposit accounts.

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: